Laboratory testing and medication prescription are two of the most important routines in daily clinical practice. Developing an artificial intelligence system that can automatically make lab test imputations and medication recommendations can save cost on potentially redundant lab tests and inform physicians in more effective prescription.
Introduction
One of the key goals of precision medicine is the ability to suggest personalized therapies to patients based on their molecular and pathophysiologic profiles [Winslow et al., 2012] . Much work has been devoted to pharmacogenomics that investigates the link between patient molecular profiles and drug response [Karczewski et al., 2012] . However, the status quo is that patient genomics data is often limited while clinical phenotypic data is ubiquitously available. Thus there is great potential in linking patient pathophysiologic profiles to medication recommendation, a direction we termed as "pharmacophenomics" that is understudied yet will soon become imperative. This approach is particularly interesting * Contact Author for cancer treatment given the heterogeneous nature of the disease. In treating cancer patients, physicians typically prescribe medications based on their knowledge and experience. However, due to knowledge gaps or unintended biases, often times these clinical decisions can be sub-optimal.
On the other hand, the data quality issue often represents one of the major impediments of utilizing Electronic Health Record (EHR) data [Kohane, 2015] . Unlike experimental data that are collected per a research protocol, the primary role of clinical data is to help clinicians care for patients, so the procedures for its collection are often neither systematic nor on a regular schedule but rather guided by patient condition and clinical or administrative requirements. Thus, many aspects of patients' clinical states may be unmeasured, unrecorded and unknown in most patients at most time points. While this "missing data" may be fully clinically appropriate, machine learning algorithms cannot directly accommodate missing data. Accordingly, missing clinical phenotypic data (e.g., laboratory test data) can hinder EHR knowledge discovery and medication recommendation efforts.
In this paper, we model the complex relations between multiple types of medical entities with their inherent features in a heterogeneous graph, named Medical Graph (MedGraph) , and propose a medical Graph Convolutional Networks (MedGCN) to learn the graph representations for better medication recommendation and lab test imputation. Figure  1 shows a MedGraph consisting of four types of nodes (i.e., encounters, patients, labs and medications), each of which could have their inherent features, e.g., demographic features for patients and the chemical composition for medications. Graph edges encode the relations between the medical entities, for example, a patient may have several encounters, an encounter may include some lab tests with certain values and some medication prescriptions. Figure 1 shows scenarios (e.g., encounters 3 and 4) where we may need to impute missing lab test results and may need to recommend partial of full list of medications.
To achieve the two tasks in one model, we propose MedGCN based on the idea of Graph Convolutional Networks (GCN). Our main contributions are as follows. (1) MedGCN extends the GCN model to heterogeneous graphs and missing feature values in medical settings. (2) We introduce cross regularization, an effective regularization technique to reduce overfittings using one task to regularize the 2 Related Work
Medication Recommendation
Following the categorization from [Shang et al., 2019] , there are mainly two types of deep learning methods designed for medication recommendation: instance-based methods and Longitudinal methods. instance based methods perform recommendations ignoring the longitudinal patient history, e.g. LEAP [Zhang et al., 2017] formulated treatment recommendation as a reinforcement learning problem to predict combination of medications given patient's diagnoses. Longitudinal methods leverage the temporal dependencies within longitudinal patient history to predict future medication, e.g., DMNC [Le et al., 2018] considers the interactions between two sequences of drug prescription and disease progression in the model. GAMENet [Shang et al., 2019 ] models longitudinal patient records in order to provide safe medication recommendation. However, these work focused on one task while not considering how other tasks affect this task. In this work, we make the recommendation based on a heterogeneous MedGraph that incorporates the complex relations between multiple types of medical entities.
Lab Test Imputation
Clinical data often contain missing values for test results. Imputation uses available data and relationships contained within it to predict point or interval estimates for missing values. Numerous imputation algorithms are available [Waljee et al., 2013; Buuren and Groothuis-Oudshoorn, 2010; Luo et al., 2016; Stekhoven and Bühlmann, 2011] , many of these are designed for cross-sectional imputation (measurements at the same time point). Recent imputation studies have attempted to model the time dimension [He et al., 2011; Kliethermes and Oleson, 2014 ], but they generally consider all time points to occur within the same patient encounters where the temporal correlation between these time points are strong enough to contribute to imputation accuracy. In our work, the lab test imputation is based on a MedGraph that incorporates multiple types of medical entities and their relations.
Graph Convolutional Networks
Recently, graph convolutional networks (GCN) attracted wide attention for inducing informative representations of nodes and edges, and could be effective for tasks that could have rich relational information between different entities [Kipf and Welling, 2017; Hamilton et al., 2017a; Li et al., 2018b; Yao et al., 2018] . GCN learns node representations based on the node features and their connections with the following propagation rule for an undirected graph [Kipf and Welling, 2017] :
whereÃ = A + I is the adjacency matrix with added selfconnection,D is a diagonal matrix withD ii = jÃ ij , H
and W (k) are the node representation matrix and the trainable parameter matrix for the kth layer, H (0) can be regarded as the original feature matrix, φ(·) is the activation function.
However, there are two issues that must be effectively tackled before extending the original GCN to MedGraph: (1) the original GCN was designed for homogeneous graphs where all the nodes are of the same type and have the same features, i.e., the original feature matrix H (0) should be constructed with the same features for all the nodes. (2) the original GCN could not handle missing values in the node features, i.e., there should not be missing values in feature matrix A. In medical scenes, a MedGraph could have multiple types of nodes with different features, and there are many missing values in the feature matrix. In this paper, we propose a Medical Graph Convolutional Network model (MedGCN) that could tackle the above issues for MedGraph, and could learn informative distributed representations for each node of MedGraph, base on which, we can not only make medication recommendation, but also can estimate the missed lab test values that have not been taken for previous or current encounters.
Methods

Problem Formulation
Though many types of medical information can be modeled into a MedGraph, in this paper, to simplify the problem, we only consider four types of medical entities (i.e., encounters, patients, labs and medications) and their relations. The methods can be easily generalized to more entities and relations.
Medication recommendation as multi-label classification
Since an encounter may include multiple medications, we model medication recommendation as a multi-label classification problem. For each medication, the model should output the recommendation probability. If an informative representation can be learned for each encounter, this problem can be tackled by many traditional machine learning algorithms like logistic regression. Thus the problem is how to effectively integrate the lab information and patient information in encounter representation learning.
Lab test imputation as matrix completion
Missing lab values imputation is another challenge in encounter representation learning. Using an encounter-by-lab matrix, the imputation problem can be formulated as a matrix completion problem. Common imputation method such as mean or median imputation will overlook the correlation between different columns. In the medical setting, the concurrent information such as patients' baselines and medications are also useful for lab test imputation. We integrate all these information in the encounter representations to help impute the missing labs.
We conduct the two medical tasks with one model MedGCN where each node can get information from its neighbors in a layer, and eventually the encounter nodes could learn informative representations that be used for both medication recommendation and lab test imputation. In addition, we can train the model with a cross regularization technique by which the loss of one task can be regarded as a regularization item for the other task.
MedGraph
We define MedGraph as a specialized graph G = (V, E) where the nodes V consists of medical entities and the edges E consists the relations between the medical entities. MedGraph is a heterogeneous graph where the nodes V consists of multiple types of medical entities. For each type of medical entity, there could be a feature matrix to represent this type of nodes. In this paper, we will construct a heterogeneous MedGraph, and apply GCN to learn the node embeddings.
GCN cannot directly handle the missing values in a node feature, but can accept an empty edge between two nodes. This leads to difficulty if one wants to use labs as features for encounters due to many missing values labs. Instead, we represent the labs as nodes of type "lab" that connect with the encounter node, i.e., we construct a bipartite subgraph between labs and encounters as part of MedGraph.
The nodes of our MedGraph consists of the the four types of medical entities, i.e., V = {E, P, L, M }, each node could have inherent features within it. The relations between two types of nodes correspond to an adjacency matrix. We defined the relations between two types of nodes as follows, and the example adjacency matrices corresponding to the MedGraph in Figure 1 are shown in Figure 2 .
• The relations between encounters and patients are defined in matrix A E×P in Figure 2 . If an encounter belongs to a patient, there is an edge between the two nodes, the corresponding position of the adjacency matrix A E×P is set to 1, otherwise, 0. We assume one encounter must belong to one and only one patient, and a patient may have several encounters, there is only one "1" in each row of the matrix A E×P .
• The relations between encounters and labs are defined in matrix A E×L in Figure 2 . If an encounter includes a lab test, there is a weighted edge between the two nodes, the corresponding position of the adjacency matrix A E×L is set to the normalized test value between 0 and 1, otherwise, 0. To discriminate the true test value 0 and the missing value in the training process, we set another mask matrix where the corresponding values are set to 1 in true test positions. For example, if the L1 test value of E2 is 0, the (E2, L1) position is 0 in the A E×L matrix, while is 1 in the mask M E×L matrix (Figure 2 ).
• The relations between encounters and medications are defined in matrix A E×M in Figure 2 . If an encounter includes a medication, there is an edge between the two nodes, the corresponding position of the adjacency matrix A E×M is set to 1.
• There are no relations between nodes within the same type except the node itself. The adjacency matrices are all set as identity matrix.
Medgraph can be generalized to more relations, e.g., if medication similarities are known, we could construct a N M × N M matrix to represent the relations between medications. However, such similarity information often requires external knowledge source that are not always available and may be subjective, thus we only consider the above 3 types of relations in this work. Also note that we did not use diagnosis code for two reasons. Diagnosis code often are recorded for billing purposes and may not reflect patients' true pathology. Moreover, we want to make MedGCN more practically useful by not asking physicians to do the heavy lifting in diagnostic reasoning.
Heterogeneous GCN
The propagation rule of GCN can be interpreted as the Laplacian smoothing [Li et al., 2018a] , i.e., the new feature of a node is computed as the weighted average of itself and its neighbors', followed by a linear transformation. Further, GCN can be generalized to a graph neural network where each node can get and integrate messages from its neighborhood to update its representation [Morris et al., 2019; Hamilton et al., 2017b] , i.e., a node v's representation is updated by 
Eq. 3 is designed for a homogeneous graph where all the samples inÑ (v) = N (v) ∪ {v} share the same linear transformation W (k) . It can be shown that Eq. 3 is equivalent to Eq. 1 except for a normalization coefficient. Though Eq. 1 cannot be directly extended to a heterogeneous graph, Eq. 3 can by recasting it as Eq. 4.
whereÑ i (v) denotes the ith type of nodes in the neighborhood of v (v included). We can write Eq. 4 in matrix form as:
where
is the presentation of the ith type nodes in the kth layer, A ij is the adjacency matrix between nodes type i and j, W (k) j is the learnable linear transformation matrix for type i nodes in layer k.
MedGCN
Applying the propagation rule Eq. 5 to our MedGraph defined in Section 3.2, we design our MedGCN architecture as shown in Figure 3 . In Figure 3 , because encounters have connections to patients, labs and medications, an encounter node update its representation based on information from neighbors of these types and itself. Similarly, a patient node update its representation based on its encounters and itself, and lab nodes, medication nodes all update their information based on their neighbor encounters and themselves. Eventually, in the last layer, each nodes would learn a distributed representation. The representations are then input to two different neural networks followed by a sigmoid layer for medication recommendation and lab test imputation, respectively.
where for each encounter, the output P = {p ij |i = 1, · · · , N E ; j = 1, · · · , N M } is the recommendation probability of medication j for encounter i. V = {v ij |i = 1, · · · , N E ; j = 1, · · · , N L } is the estimated value of lab j for encounter i.
Loss function
For the medication recommendation task, the true label is the adjacency matrix A E×M . Since A E×M is very sparse, to favor the learning of positive classes, we give a weight N n /N p to the positive classes, where N n and N p are the number of '0's and '1's in A E×M , respectively. The binary cross entropy loss for medication recommendation is defined as
where a ij and p ij are the values at position (i, j) in matrix A and P respectively.
For the lab test imputation task, the true value is in the adjacency matrix A E×L . Since all the missing values are set to '0's in A E×L which are not the training targets, we use the mask matrix M E×L to screen the true targets. Since the lab value are continuous, we use the mean square error loss for lab test imputation as
where a ij , v ij and m ij are the values at position (i, j) in matrix A, V and M respectively.
To learn a MedGCN model that can perform the two tasks, we use the loss Eq. 9, where λ is used to adjust the proportion of the two losses.
Training strategies: cross regularization Generally, for medication recommendation task, we only need L M loss, and for lab test imputation, we only need L L loss. Nevertheless, even for only one task, we propose to use the sum loss function Eq. 9. It is a cross regularization technique between two tasks, i.e., using other tasks to regularize the target task to reduce overfitting. Beneficially, cross regularization could make the learned representations more informative, because they would carry information from other tasks. In this work, when considering the medication recommendation task, λL L can serve as a regularization item that makes the learned encounter representation carry lab information; conversely, when considering the lab test imputation task, L M plays the role of regularization. We will show that cross regularization can perform better than using only one loss in the experiments.
Inductive test
The original GCN is considered transductive, there are some improved versions based on it for inductive test for new samples [Hamilton et al., 2017a; . Our MedGCN can be inductive based on Eq. 4, for a new test sample v with its connections, since all the node embeddings of the graph and the weights of each layer are learned, the embedding of neighbors of v could be retrieved to compute the embedding of v by Eq. 4 without retraining the model.
Experiments
Data Sources
We test our MedGCN using real EHR data from a tertiary care hospital. We select the cohort where the patients have been diagnosed lung cancer (ICD9=162.x or 231.2, they are necessary for defining the patient cohort), excluding the encounters 
are hidden representations of corresponding nodes at layer k. Figure  1 . The dataset and MedGraph information are summarized in Table 1 .
Preprocessing
We split the dataset into a train-val set and a test set with proportion 8:2, the train-val set is further split into training set and val set by 9:1. Specifically, for medication recommendation task, the encounters are split into training, validation and test. In the training process, we remove all edges from the test and validation encounters to any medications in MedGraph. For lab test imputation task, the edges between encounters and labs are split into training, validation and test. In the training process, we remove all validation and testing edges in MedGraph. For inductive MedGCN, we remove all testing encounters and their connections from MedGraph when training. For both tasks, in each training epoch we evaluate the performance on validation set, the training will early stop if the validation performance does not get better in 50 epochs. The best model for validation set is saved to apply on the test set.
Evaluation Settings
Since all types of nodes in the MedGraph have connections to encounters, a simple 1-layer MegGCN is enough to learn a informative representation for encounters. We set a 1-layer MedGCN with the output dimension 300 and dropout rate 0.1 in our experiments. We implement MedGCN with PyTorch 1.0.1, and train it using Adam optimizer [Kingma and Ba, 2015] with learning rate 0.001. The max training epochs is 1000. The cross regularization coefficient λ = 1, we also set other values for λ, but find λ = 1 performance best.
Baselines
For medication recommendation, we consider several baseline classification algorithms implemented for multi-label classification. Our method and baselines are list in Table 2 in the first column. For the baselines that can not handle missing values, we simply replace missing values with 0. We have also tried replace missing values with mean values, the results did not show any differences. All baselines are implemented with scikit-learn [Pedregosa et al., 2011] . For lab test imputation, we consider several baselines implemented for matrix completion. Our method and baselines are list in Table 3 in the first column. Since the 3 baselines can only process discrete data, when testing the baselines, we discretize the continuous lab value into 5 ratings for each column in advance.
Metrics
We use label ranking average precision (LRAP) and mean average precision at 2 (MAP@2) to measure the performance of medication recommendation, since the average number of medications for an encounter is 2. Higher LRAP or MAP means more accuracy recommendation. We use mean square error (MSE) to measure the performance of lab test imputation.
Results
For MedGCN, we execute the training and test precess 5 times, and record the average performance and standard deviation for both medication recommendation and lab test imputation. For the baselines, we also test them 5 times and record the corresponding results on their own task.
The results for medication recommendation of our model and the baselines are listed in [Friedman, 2002] .6908±.0021 .6444±.0026 RF [Breiman, 2001] . .0264±.0034 MedGCN-Lab (ours) .0254±.0003 MGCNN [Monti et al., 2017] .0369±.0009 GCMC [Berg et al., 2018] .0426±.0025 GCMC+FEAT [Berg et al., 2018] .0359±.0030 The results for lab test imputation are listed in Table 3 . The results in Table 3 show MedGCN can significantly perform better than all the baselines. Comparing the performance of MedGCN-Lab and MedGCN, we can also validate the efficacy of the cross regularization. From Table 2 and 3, although the test encounters and their connections are removed from MedGraph in the training process, the inductive MedGCN implemented according to 4 can also have good performances for both medication recommendation and lab test imputation.
The main reason why MedGCN works well are two fold: (1) Because the MedGraph incorporates the complex relations between different medical entities, MedGCN built on the informative MedGraph has the potential to learn a much informative representations for each nodes. (2) To make this potential into reality, the cross regularization technique makes the learned representation predictive for multiple tasks. Considering the baselines in Table 2 , they all miss the correlations between the multiple medications, while MedGCN consider the relations between medications through their shared encounters. In MedGCN-Med, since encounters have got information from medications, just minimizing loss Eq. 7 to learn representations predictive to medications will overfit the training data. MedGCN with cross regularization technique reduces this overfitting, learns more informative representa- tions and performs better, it can also be validated by comparing the results of MedGCN and MedGCN-Lab in Table 3 for lab test imputation. Because the baselines in Table 3 miss the medication and patient information for lab test imputation, it is expected that they can not perform so well as MedGCN.
Case Study
We choose an encounter that has only a few lab values available from the test set to see what medication our model will recommend, and what lab values will be imputed. As shown in Table 4 , an encounter has two available labs on urine analysis. Of note, albuminuria was shown to associate with a 2.4-fold likelihood of risk of lung cancer [Jørgensen et al., 2008] . For medication recommendation, the true medications are prescribed by doctors and the top 5 recommended medications by different methods are listed in the upper part of Table 4 . No priority in the true medications, sequence priority exists in the model recommendations. We found the top 3 recommendations of MedGCN are exactly the doctor prescribed medications. LR and MLP missed one medication in the top 5 recommendations; GBDT recommends a lower priority for gem. For lab test imputation for the same encounter, the true value of lab urobi was taken as 0.2, but we removed it in the training process. The estimation of this value are listed in the lower part of Table 4 . We can see that our MedGCN predicts closer to the true value than the baselines. In addition, MedGCN can perform the two tasks simultaneously.
Conclusion
In this paper, we proposed MedGCN, an end-to-end graph embedding model that could learn informative medical entity representations for multiple medical tasks. We augmented MedGCN to handle heterogeneous MedGraph by formulating different medical entities different types of nodes. By transforming node features to a new type of nodes in the graph, MedGCN can also handle missing values in the features of a medical entity. MedGCN is an general inductive model that could use the learned node representations and network weights to efficiently generate representation for new nodes. In addition, we introduce cross regularization to reduce overfittings by making the learned representation more informative. Experimental results on a real medical dataset showed that MedGCN outperformed state-of-the-art methods in both medication recommendation and lab test imputation tasks. Our future work includes integrating existing knowledge graphs in the construction of MedGraph, and applying MedGCN to more cancerous and noncancerous diseases.
